Marimed (MRMD) Gains from Investment Securities (2011 - 2026)

Marimed (MRMD) has 13 years of Gains from Investment Securities data on file, last reported at $46000.0 in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $46000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$788000.0 (down 49.81% YoY), and the FY2025 annual result was -$834000.0, down 6315.38% from the prior year.
• Gains from Investment Securities climbed to $46000.0 in Q1 2026 per MRMD's latest filing, from -$589000.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $6.1 million in Q4 2023 and troughed at -$1.5 million in Q3 2023.
• A 5-year average of $382933.3 and a median of $64000.0 in 2022 frame the typical range for Gains from Investment Securities.
• On a YoY basis, Gains from Investment Securities climbed as much as 15397.5% in 2023 and fell as far as 2389.06% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at -$40000.0 in 2022, then soared by 15397.5% to $6.1 million in 2023, then slumped by 100.54% to -$33000.0 in 2024, then sank by 1684.85% to -$589000.0 in 2025, then surged by 107.81% to $46000.0 in 2026.
• Business Quant data shows MRMD's Gains from Investment Securities at $46000.0 in Q1 2026, -$589000.0 in Q4 2025, and -$871000.0 in Q3 2025.